Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.
17h
Hosted on MSNWill Eli Lilly Stock Keep Climbing? Q2 Trial Results Are CrucialEli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...
18h
Zacks.com on MSNLLY Rises More Than 4% in a Week: How to Play the StockEli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...
The president said advisers would devise new tariff levels reflecting countries’ tariffs, taxes, subsidies and other policies affecting trade with the United States. Tens of thousands of ...
Trump Says He Will Rework Global Trading Relations With ‘Reciprocal’ Tariffs President Trump signed a memorandum ordering his advisers to calculate new tariff levels for other countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results